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Investigation of brain tissue 
infiltration by medulloblastoma 
cells in an ex vivo model
Anuja Neve1, Karthiga Santhana Kumar1, Dimitra Tripolitsioti1, Michael A. Grotzer1,2 & Martin 
Baumgartner  1
Medulloblastoma (MB) is a paediatric cancer of the cerebellum that can develop cerebellar and 
leptomeningeal metastases. Local brain tissue infiltration, the underlying cause of metastasis and 
relapse, remains unexplored. We developed a novel approach to investigate tissue infiltration of MB 
using organotypic cerebellum slice culture (OCSC). We show that cellular and structural components 
of cerebellar tissue in OCSCs are maintained for up to 30 days ex vivo, and that OCSCs foster tumour 
growth and cell proliferation. Using cell-based models of sonic hedgehog (SHH) and group 3 (G3) MB, 
we quantified tumour growth and infiltration and determined the morphological characteristics of 
the infiltrating cells. We observed basal levels of dissemination occurring in both subgroups with cells 
migrating either individually or collectively as clusters. Collective cerebellar tissue infiltration of SHH 
MB cells was further enhanced by EGF but not HGF, demonstrating differential tumour cell responses to 
microenvironmental cues. We found G3 cells to be hyper proliferative and observed aggressive tumour 
expansion even in the absence of exogenous growth factors. Our study thus provides unprecedented 
insights into brain tissue infiltration of SHH and G3 MB cells and reveals the cellular basis of the tumour 
progressing functions of EGF in SHH MB.
Medulloblastoma (MB) is the most common malignant paediatric brain tumour. It accounts for 15–20% of all 
childhood nervous system tumours1 with peak incidence rates at 6 children per million under 9 years of age2. 
Earlier thought of as a single disease entity, it is now well known that MB is comprised of at least four distinct 
molecular subtypes, namely, Wnt, sonic hedgehog (SHH), group 3 and group 43. These subgroups remain stable 
in metastatic and recurrent disease4. MB arises in the cerebellum and is characterised by leptomeningeal dis-
semination to the brain and spinal cord. Surgery, radiotherapy and chemotherapy remain the current treatment 
modalities that have brought MB to a manageable condition for up to 70% of patients. However, MB survivors 
suffer from long lasting radiotherapy-induced side effects and despite the increasing understanding of the genetic 
and epigenetic hallmarks and differences in the different MB subgroups, an efficacious targeted therapy is still 
not available.
In vitro techniques used to address the lack of suitable therapy approaches do yield rapid results, which how-
ever may fall short of clinical relevance due to the failure of in vitro systems to mimic the complex natural tumour 
microenvironment. This is especially true in the case of long-established cell-lines that get easily adapted to the 
in vitro cell culture conditions. Therefore, genetically engineered mouse models of MB have been established 
to further study the molecular and cellular basis of tumour development. These include SHH signalling based 
models5–7, Tp53 mutation based models8, Sleeping beauty mutagenesis models9, 10 and the MYCN-driven GTML 
mouse model11. On the one hand, these genetic mouse models allow straightforward evaluation of tumour devel-
opment and monitoring of tumour size and location of the metastases. On the other hand, addressing local infil-
tration into the cerebellar tissue adjacent the tumour poses a challenge as the optimal time-point for analysis may 
greatly differ between the animals. An excellent alternative to genetic mouse models is the orthotopic implan-
tation of patient-derived tumour cells and their further in vivo propagation12–16. However, accurate orthotopic 
implantation is a technically challenging approach and screening of therapeutic targets and testing the efficacy of 
potential drugs is rather inefficient and very costly using these models.
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This calls for the development of an appropriate system that would use a normal brain component such as the 
cerebellum along with the MB tumour and bridge the current gap between in vitro and in vivo research. One such 
system is the organotypic cerebellar slice culture (OCSC), which entails the culturing, maintenance and long term 
survival of cerebellar slices ex vivo under physiological conditions17. This ex vivo model retains the cytoarchitec-
ture as seen in the original tissue, and the extracellular matrix components closely resemble the in vivo situation. 
OCSCs have been widely used in neurobiology and brain slice cultures have recently also been used in the context 
of MB to test for the uptake and mobility of poly glycerol-adipate nanoparticles18 and for drug therapy using 
Smoothened antagonist LDE22519.
Marked genetic divergence in primary tumour compared to matched metastases have been described recently 
in experimental animal models and human patient samples20. This genetic divergence underscores the bicom-
partmental nature of primary and metastatic MB already recognized some time ago, when a set of putative metas-
tasis driver genes had been identified10. Current models have thus focused on genetic events associated with 
or accumulated in metastases. Still largely unresolved questions are which of the metastasis-associated genetic 
events encode the cellular functions that drive dissemination away from the primary tumour and whether spe-
cific cellular or topological characteristics of the cerebellar microenvironment facilitate tissue infiltration. This is 
particularly relevant in light of the consensus reached recently on the high risk associated with metastatic MB, in 
particular also for SHH and group 3 MB21.
To identify intrinsic and microenvironmental mediators of brain tissue infiltration in MB, we have developed 
a cerebellar-MB tumour cell ex vivo co-culture system where SHH and Group 3 tumour spheroids are implanted 
on the organotypic cerebellar slice cultures. Using various molecular markers to identify the cellular components 
of the cerebellum by immunofluorescence and combining this with confocal microscopy, we have studied the 
dissemination and local infiltration of MB tumour cells. We demonstrate the suitability of this model for the effi-
cient pre-clinical evaluation of anti-infiltration strategies, which would be instrumental to design and test novel 
treatment approaches as anti-metastatic therapies.
Results
The cerebellar slice- tumour cells co-culture. In order to set up the ex vivo model, cerebella were dis-
sected from mice pups at postnatal day (PND) 8–10, sliced and put in culture under physiological conditions 
(Fig. 1A). PND 8–10 corresponds approximately to the neurodevelopmental stage of a new-born infant22. Since 
one of the locations for the occurrence of childhood MB is close to the vermis, cerebella were oriented in such 
a way that during sectioning we either obtained typical lobulated sagittal slices or coronal sections containing 
the vermis (Fig. 1B). The 350 µm thick slices were cultivated on membrane inserts (placed in a six well plate 
containing medium) for a suitable period of time. Spheroids of DAOY MB cells expressing LifeAct enhanced 
GFP (LA-EGFP) were then implanted on the cerebellar slices (Fig. 1A, C). One spheroid was implanted per slice 
and this was verified under the microscope one day post spheroid implantation. This organotypic cerebellar 
slice-tumour spheroid co-culture system was further maintained in vitro and the study of growth and infiltration 
of tumour cells was carried out using immunofluorescence and confocal microscopy. We observed that there was 
a basal level of dissemination in the slices where tumour cells were migrating either as single cells (asterisk) or in 
clusters (arrowheads) (Fig. 1D).
Determination of a suitable time point for the implantation of tumour spheroids and study 
of tumour cell dynamics in the OCSCs. A critical step in the establishment of the co-culture model is 
determining the time point suitable for the implantation of the tumour spheroid. Hence, we studied the mor-
phological changes in the cerebellar architecture of the slices at various time points namely: day in vitro (DIV) 0, 
DIV 1, DIV 10 and DIV 21 using immunofluorescence. We observed that at DIV 1, the characteristic Purkinje 
cell monolayer (red) observed at DIV 0 was lost. This could be due to the inevitable trimming of certain axons 
during cerebellar sectioning. However, as the culturing time progressed, a gradual re-organisation in the slices 
was observed, possibly due to the establishment of new synaptic connections. Between DIV 15 and DIV 21, an 
orderly arrangement of the Purkinje cells was visible in most parts of the culture. By DIV 21, the thickness of the 
slices was reduced and the Purkinje cell layer (PCL) was established in close proximity to the arrangement at DIV 
0 (Fig. 2A). Furthermore, between DIV 10 and DIV 21, the presence of axon collaterals that ran into the inner 
granular layer and dendritic spines that formed extensive branches indicated slice maturation (Fig. 2B). Based 
on this, DIV 15 was selected as a time point suitable for the implantation of the tumour spheroids and the slice 
culture protocol was accordingly adjusted. Figure 2C shows the timeline of the procedures with the analysis of 
the implanted spheroids between 5 and 15 days after implantation (DIV 20 – DIV 30). Using markers to iden-
tify the different layers within the cerebellar cortex (Fig. 2D) and the vasculature (Fig. 2E), we investigated any 
possible alterations in tissue organization between DIV 0 and DIV 15. At DIV 15, we observed a clearly layered 
organization in lobules with the granular layer (GL) embedded within an array of Purkinje cells. The robust vas-
culature observed using anti-Collagen IV staining at DIV 0 appeared to thin down/flatten and reorganise with 
new endothelial network in mature slices at DIV 15. To evaluate the extents of proliferation both in the tumour 
cells as well as the slice culture at DIV 20 (5 days of co-culture), we performed 5-ethynyl-2′-deoxyuridine (EdU) 
staining followed by detection with a fluorescent azide through a Cu(I)-catalysed [3 + 2] cycloaddition reaction 
(“click” chemistry). To determine the number of apoptotic cells, we stained for cleaved caspase 3. We found that 
the LA-EGFP-positive tumour cells displayed a mixed population of cells – with a majority of cells proliferating 
and less than 10% of them positive for cleaved caspase 3 (Fig. 2F). A few EdU-positive cells were also detected in 
the slice, while caspase 3 cleavage levels above background were not detectable. When the co-culture was main-
tained for 5 days in vitro, the disseminating tumour cells showed characteristic lamellipodia and mesenchymal 
morphology with a rear-front cell polarity (Fig. 2G). Upon 15 days of co-culture initiation, we observed distinct 
migration of tumour cells and these migrating cells were in the vicinity of the endothelial network (Fig. 2H).
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We concluded that the optimal time-point for tumour spheroid implantation is at DIV 15. Implanted tumour 
cells proliferate and only a small proportion of the tumour cells show signs of cell death. Thus, the co-cultured 
tumour cells are viable, proliferative, infiltrate the cerebellar tissue and do not affect the viability of the cellular 
components of the host tissue.
Qualitative and quantitative study of MB cell migration and tumour mass using 
OCSC. Qualitative and quantitative analysis of MB cell dissemination are essential prerequisites for the eval-
uation of tumour cell behaviour, especially after the application of an experimental preclinical treatment. Since 
the infiltration of the healthy cerebellar tissue by transformed MB cells requires cell motility, we qualitatively 
assessed the morphological characteristics of migrating MB cells in the cerebellar slices after 5 days of co-culture 
initiation. We used DAOY MB cells expressing LA-EGFP to allow visualisation and analysis of the cytoskeleton. 
We observed that even in the absence of an exogenous stimulation, MB cells infiltrated in a mixed phenotype 
with both single and clusters of infiltrating cells (Fig. 3A). Infiltrating cells were elongated and characterised by 
long extensions and marked lamellipodia and filopodia-like protrusions comprised of F-actin mesh works and 
bundles (Fig. 3A, c-e, arrows). We also observed brain tissue infiltration with the human SHH MB line UW228 
(Fig. S2), the G3 MB line HD-MB03 (Fig. 5B), as well as the two primary glioblastoma cell lines ZH411 and 
ZH561 (Fig. S1).
For quantitative analysis, we allowed the tumour cells to grow and disseminate for 12 days after implanta-
tion into a coronal section. The co-culture was then fixed and stained for calbindin and microscopically investi-
gated (Fig. 3B). We observed distinct separation of a secondary cluster of tumour cells from the primary tumour 
cell cluster and active further dissemination of LA-EGFP-positive cells inside the cerebellar tissue. Orthogonal 
sections revealed that these cells had indeed infiltrated into the tissue and were not present just at the surface 
(Fig. 3C). To determine how far the cells had disseminated from the secondary cluster in the tissue, we quan-
tified the distance of migration of the tertiary clusters from the centre of cluster 6 (secondary cluster, Fig. 3D). 
We volumised the individual secondary and tertiary clusters (Fig. 3C and D) and quantified their volumes to get 
Figure 1. The organotypic cerebellar slice–tumour co-culture. (A) Workflow for OCSC generation and 
tumour spheroid implantation. (1) Decapitation of mouse pup(s) at PND 8–10 and isolation of cerebellum. (2) 
Sectioning of cerebellum under physiological conditions using a vibratome to generate 350 µm thick sagittal 
or coronal sections. (3) Culture of cerebellum sections on membrane inserts for 15 days in vitro (DIV). (4) 
Implantation of one LifeAct enhanced GFP (LA-EGFP) expressing tumour spheroid per slice. (5) Further 
incubation of the co-culture in vitro without or with treatment. (6) Fixation and immunofluorescence for 
microscopy analysis. (7) Quantification and data analysis. (B) Sagittal and coronal sections of cerebella, 
stained with anti-Calbindin (red) to visualise Purkinje cells. (C) Implantation of LA-EGFP expressing DAOY 
cells spheroid on the slices. (D) Dissemination of tumour cells (green) in the cerebellar slices after 5 days post 
initiation of culture.
www.nature.com/scientificreports/
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Figure 2. Morphological assessments of the cerebellar slices and co-culture in vitro. (A) Changes in the 
Purkinje cell monolayer upon in vitro culturing of the slices was monitored at DIV 0, DIV 1, DIV 10 and DIV 
21 with anti-calbindin antibody (red) using confocal microscopy. (B) Grey scale images of cerebellar slices 
at DIV 0 and after being cultured for DIV 21. (C) Timeline of the experimental setup for five-day co-culture 
experiment. DIV 15 was selected as the time point suitable for the implantation of tumour spheroid. (D) 
The cerebellar cortex layers visualised using confocal microscopy at DIV 0 and DIV 15 for comparison with 
anti-Calbindin (red, Purkinje cell layer) and anti-NeuN (green, granular layer) antibodies. (E) Visualisation 
of the vasculature using anti-collagen IV (grey) at DIV 0 and DIV 15. (F) Determination of apoptosis and 
proliferation after five-day co-culture using anti-cleaved caspase 3 (red) and Click-iT EdU (blue), respectively. 
(G) Monitoring the tumour cells infiltrating the cerebellar slices. (H) Visualization of the vasculature (blue) in 
the presence of tumour cells. Lower panels: zoomed versions of boxed insets in F, G and H respectively. In H, 
EGFP and Collagen IV fluorescence was volumised.
www.nature.com/scientificreports/
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Figure 3. Qualitative and quantitative analysis of MB cell behaviour in co-culture. (A) Visualisation of the 
co-culture initiated for 5 days. Morphological assessment of the invading cells was performed (boxed insets 
a to e and their respective zoomed in versions). (B) Purkinje cell/tumour cell co-culture visualisation 12 days 
after implantation. (C) Zoomed version of the boxed area in A and its orthogonal view. (D) Volumisation of the 
tumour clusters in B using Imaris. Graphical representation of the distance of the satellite tumour cells from the 
tumour cluster 6 (E) and tumour volume (F). Inverted grey scale images show individual channels for better 
visualisation of cellular structures. a - e are 63x zoomed-in images of the yellow boxed areas. Arrows point to 
invasive lamellipodia- and filopodia-like protrusions in invading cells.
www.nature.com/scientificreports/
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Figure 4. Quantification of relative growth and proliferation in response to HGF or EGF stimulation. (A) 
Confocal microscopy analysis of DAOY LA-EGFP cells spheroid co-cultured for five days in the OCSCs and 
exposed to the growth factors as indicated. EGFP signal was volumised and volume quantified. EdU-positive 
nuclei were marked and counted as well. (B) Quantification of volume, occupancy (tumour area/slice area) and 
number of EdU-positive nuclei. Mean and SD of two independent experiments are shown. ANOVA statistical 
analysis was performed (* = p < 0.05). (C) Higher magnification of EGF-stimulated DAOY cells invading 
the molecular layer. D) Purple asterisks in LA-EGFP grey scale panel highlight the proliferating cells. E) 
Magnification of the invasion front (boxed inset in (D). Inverted grey scale image shows F-actin cytoskeleton 
of leading edge cells with distinct filopodia and lamellipodia (arrows). (F) EGF-induced invasion of DAOY 
cells into molecular layer (green: LA-EGFP, red: anti-Calbindin). Orthogonal XYZ section shows infiltration 
of tumour cells into Purkinje cell layer. Red and green channels are also shown as inverted grey scale images 
for better visualization of the different layers. (G) Comparison of growth and invasion of untreated and EGF-
www.nature.com/scientificreports/
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insight in their relative sizes. We quantified volumes around 5000 to 10,000 μm3 in the tertiary clusters (Fig. 3F) 
and localized them in a distance of 200 to 400 µm from secondary cluster 6 (Fig. 3E).
These data show that OCSCs can be used to study the migration dynamics of MB cells in the cerebellar slices 
and to quantitatively address dissemination distances and volumes of individual tumour cells/clusters. They fur-
thermore indicate that the disseminating cells either individualise immediately after cell division or do not pro-
liferate massively and remain quiescent.
EGF promotes sheet-like cerebellar tissue invasion in cell model of SHH MB. In previous studies, 
we identified hepatocyte growth factor (HGF) and epidermal growth factor (EGF) as powerful pro-migratory 
growth factors for MB in vitro23, 24. In order to determine their biological relevance for MB tissue infiltration, we 
treated cerebellar slice-MB tumour cell co-culture with either HGF or EGF and measured the change(s) in the 
tumour cell dynamics/tumour cell growth and proliferation compared to the untreated control after five days 
of continuous treatment. Interestingly and in contrast to the data of our in vitro studies, HGF did not stimulate 
migration over and above what we observed in untreated cells. In contrast, EGF elicited a very distinct tumour 
cell behaviour, both in DAOY (Fig. 4A) and UW228 (Fig. 4G) cells. In parallel, we also determined the number 
of nuclei having incorporated EdU, to estimate differences in proliferation under the three conditions. A much 
larger number of EdU-positive nuclei were detected in EGF-stimulated cells compared to HGF-treated or control 
cells (Fig. 4B). Tumour cells under EGF treatment also occupied a markedly larger slice area than in untreated 
slices (Fig. 4B). Consistently, the quantification of the volume of the LA-EGFP signal in the image stacks acquired 
from EGF-treated slices displayed a significant increase in the tumour volume compared to the untreated control 
(Fig. 4B).
Along with this, a remarkable difference in the mode of growth and infiltration/spread was observed under 
EGF-treatment, where DAOY cells expanded into the cerebellar tissue in a compact sheet in which cell-cell con-
tacts remained intact. The invasion front of the EGF-stimulated cells was oriented towards the molecular layer 
(Fig. 4C). EdU incorporation indicated no difference in proliferation between the invading and non-invading 
cells as EdU positivity could be seen both at the front of invasion as well as further inside (Fig. 4D, asterisks). The 
invading cell sheets observed in response to EGF stimulation appeared to be guided by a few leader cells at the 
invasion front. Remarkably, these leader cells displayed pronounced lamellipodia, which extended F-actin-rich, 
filopodia-like protrusions into the cerebellar tissue. (Fig. 4E, arrows). Similarly, UW228 cells invade collec-
tively when stimulated with EGF (Fig. 4G). However, unlike DAOY cells, UW228 tend to form streams of elon-
gated cells that extend several hundred microns deep into the molecular layer of the surrounding brain tissue 
(Fig. 4G,H). Marked, F-actin polymerization-driven protrusions are also clearly detectable in cells invading in 
close proximity of the tumour spheroid (Fig. 4I).
Together, these experiments confirmed EGF as a strong promoter of cell proliferation and migration in MB 
and demonstrated its potential to drive brain tissue infiltration of the tumour cells. This demonstrates that the 
ex vivo model can be used as a tool for testing the potential of various growth factors and screening of probable 
therapy targets. Our data furthermore show that during EGF-driven tissue invasion, the infiltrating cell mass is 
organized in sheets or as streams with leader cells extending marked, F-actin-rich protrusions at the invasion 
front that penetrate preferentially into the molecular layer.
SHH and group 3 MB cell grow differently in brain tissue. Our studies using DAOY and UW228 cells 
have revealed novel morphological characteristics of growth and infiltration of these SHH MB lines. To extend 
this study and to identify differences in growth and infiltration behaviour between cells of different molecular 
subgroups, we set up OCSCs with group 3 MB cells to establish the novel ex vivo model also for group 3 MB. We 
chose this subgroup because metastasizing group 3 MB is very difficult to manage in the clinic and associated 
with very high risk and poor prognosis21. We used HD-MBO3 cells that were isolated from a metastasizing group 
3 MB and which can be grown both in vitro and in vivo25. Similar to the SHH MB DAOY cells, HD-MB03 cells 
were grown into spheroids and then implanted in the cerebellum slices according to the protocol established 
for DAOY spheroids. As HD-MBO3 cells expressing LA-EGFP are not yet available, we visualised the tumour 
cells using either EdU staining or Vybrant Dil or both (Fig. 5A). 5 days after implantation of the spheroid, we 
detected a very large tumour cell mass that had expanded within the cerebellum. We compared the relative area 
covered by the SHH and group 3 tumour cell masses in the cerebellar slices. The HD-MBO3 cells expanded 
nearly three-fold more than the DAOY cells and covered 29% of the slice area (SHH: 3%) (Fig. 5A, right, 5B). 
Using another HD-MBO3-cerebellar co-culture slice, we determined whether group 3 MB cells also infiltrate 
the cerebellar tissue (Fig. 5B). We zoomed into the tumour border region and detected EdU-positive nuclei of 
the same size and appearance like those detected in the main tumour mass (Fig. 5B a & b, arrowheads). Since 
not all HD-MBO3 cells are expected to incorporate EdU, we labelled the tumour cells with the lipophilic mem-
brane stain Vybrant Dil prior to implantation, which should allow visualisation of the tumour cells by fluorescent 
microscopy. However, due to the very high proliferation rate, the dye diluted out and was detectable as perinu-
clear spots and not, as expected, in the plasma membrane (Fig. 5B). Nevertheless, the Vybrant Dil detection also 
stimulated UW228 tumour spheroids. Red arrows in LA-EGF grey-scale image indicate approximate length of 
invading cell streams. (H) Higher magnification of tissue infiltration of UW228 cells in response to EGF. Leader 
cells (green) at invasion front 600 µm deep in the host tissue and Purkinje cells (blue) are shown. Inverted 
grey scale image shows elongated F-actin cytoskeleton of the leader cell with pronounced lamellipodium. (I) 
Morphology of EGF-stimulated UW228 cells during spheroid-proximal infiltration. Image to the right shows 
volumised F-actin cytoskeleton with marked invasive protrusions.
www.nature.com/scientificreports/
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identified EdU-negative tumour cells that had infiltrated into the brain tissue (Fig. 5B c, arrows c), thus confirm-
ing that HD-MBO3 expansion in the brain slice also involves tissue infiltration of solitary tumour cells.
Thus, OCSC is also suitable for growing group 3 MB cells. Importantly, the growth rate of group 3 cells is 
markedly higher that of the SHH MB lines DAOY or UW228. Single HD-MBO3 tumour cells inside the cerebellar 
Figure 5. Massive growth and brain tissue infiltration of group 3 MB cells. (A) LA-EGFP DAOY or HD-
MBO3 cell spheroids were implanted in DIV 15 cerebellar slices and incubated for 5 days. Image show confocal 
microscopy image analysis of whole slices. Staining as indicated. Tumour area relative to whole cerebellar slice 
area was quantified (right panels) and was 2.9 and 29.0% for DAOY and HD-MBO3, respectively. (B) Growth 
of HD-MBO3 spheroid in OCSC and microscopy analysis as in (A). Inverted grey scale images show Vybrant 
Dil staining of the tumour cells. Graphical representation of the occupancy obtained from three independent 
experiments for each cell line. Means and SD are shown with statistical analysis done using unpaired, two-
tailed t-test. (a) is a higher magnification confocal image of the tumour-parenchyma border. Yellow line in (b) 
indicates tumour border and yellow arrowheads EdU-positive nuclei of infiltrating tumour cells. (c) as (a) but 
with yellow arrows pointing to EdU-negative infiltrating tumour cells identified by Vybrant Dil staining (green). 
Asterisks indicate EdU-positive nuclei of infiltrating tumour cells.
www.nature.com/scientificreports/
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tissue can be detected using the proliferation marker EdU or the lipophilic stain Vybrant Dil, suggesting that 
HD-MBO3 expands by both growth and local infiltration.
Discussion
To overcome the lack of appropriate methods for the investigation of local tissue infiltration in metastatic MB, we 
successfully established an organotypic cerebellar slice-MB tumour co-culture model system. We demonstrated 
that the host cerebellum tissue and the co-cultured tumour cells survive for up to 30 days ex vivo. Furthermore, 
the tumour cells propagated, suggesting that there was no rejection of the tumour spheroids (human) by the host 
tissue (mouse). We found that the cerebellar cytoarchitecture was well preserved and detected infiltrating tumour 
cells distant from the primary tumour spheroid. Using standard imaging software, we showed that short-range 
dissemination of tumour cells and tumour volume can be quantified. Furthermore, the treatment of MB cells of 
the SHH subtype with the growth factors HGF or EGF revealed a factor-specific response, wherein EGF strongly 
promoted growth and collective infiltration of the brain tissue. In contrast, HGF treatment induced single cell 
dissemination similar to the untreated control and did not cause an increase in tumour volume. The comparison 
of MB cells of the molecular subgroup SHH and group 3 revealed a clear growth advantage of latter. In conclusion, 
this novel ex vivo model is a valuable and versatile tool for basic and translational MB research. It mimics the 
initial stages of cerebellar tissue infiltration, and it can thus be used for the identification of growth and dissemi-
nation promoting molecular pathways and for evaluating targeting strategies to block them.
One important aspect is the implantation of MB tumour spheroids into cerebellar slices of neonatal mice, as 
opposed to the distribution of MB tumour cells on whole brain slices19 or to the implantation of tumour cells into 
a hole punctured into sliced human brain tissue26. We consider the OCSC and spheroid implantation approach 
favourable because (i) tumour cells grown as spheroids can recapitulate the natural cell-matrix interactions, and 
have gene and protein expression profiles closer to the parental tumours compared to cells grown as a mon-
olayer26–29, (ii) the time point used for the dissection of the cerebellar slices in this study corresponds to the devel-
opmental stage of infants, one of the target populations in MB and iii) the use of spheroids facilitates to observe 
and calculate the range of dissemination from the site of implantation. Latter is especially helpful when inves-
tigating the effects of compounds targeting cell migration and invasion. Previous studies19, 30 used whole brain 
slices of P6 mouse pups cultivated for 24 to 48 hours before the addition of tumour cells. This approach poses a 
marked risk of reactive gliosis that may affect tumour cell behaviour in an unpredictable manner. Moreover, its 
is well known that cerebellar brain slices reorganize during maturation31 and our analysis of the purkinje cell 
re-distribution, which is completed around DIV15, strongly argues for choosing a time point of DIV 15 or more 
for implantation.
The treatment of co-cultured SHH MB cell spheroids with EGF for five days caused massive and well quan-
tifiable dissemination of the tumour cells. This EGF-induced dissemination of MB cells occurs mostly in the 
molecular layer, suggesting that cell density and composition may guide spreading of MB in the brain. In con-
trast, when the co-culture was treated with HGF alone, no appreciable increase of tumour mass over the controls 
was observed using volumetric analysis despite a moderate increase in slice occupancy. This data diverged from 
the previously described pro-migratory function of HGF in MB23, 24, 32, 33. Although we do not fully understand 
this discrepancy yet, it is possible that HGF stimulation causes a diffuse infiltration of single cells into the cer-
ebellum tissue with no apparent proliferation of the primary tumour mass. A similar observation with diffuse 
brain slice infiltration and a reduction of the spheroid mass was noted with primary glioblastoma cells34 and our 
study using primary glioblastoma-derived cells confirmed diffuse infiltration with small increases in volume and 
cell number only. Upon extended co-culture (12 + days), we observed that the single infiltrating cells displayed 
reduced LA-EGFP expression. We tried to highlight EGFP-dim cells using anti-CD47 (data not shown), which 
clearly labelled the tumour cells in the spheroid but failed to clearly detect the disseminated cells. Thus, there is 
a possibility wherein single MB tumour cells in untreated/HGF co-culture did disseminate effectively as well but 
their microscopy detection failed due to low fluorescence. Hence, for the analysis of diffusely infiltrating cells, 
the establishment of a fluorophore tagging strategy ensuring bright fluorescence is an essential prerequisite that 
needs to be established in a cell and condition-specific manner. As an alternative approach, we recommend using 
anti-human nuclei antibody, which highlights the nuclei of the human tumour cells only and can therefore be 
easily used to detect primary human tumour material in short- and long-term co-culture experiments.
The formation of F-actin-rich, lamellipodia and filopodia-like protrusions at the leading edge of invading 
cells hallmark both single and collective cell infiltration. It is thus conceivable that those protrusions are not 
only associated with but causative for cerebellar tissue infiltration, as was recently proposed more generally for 
the invasion of solid tumours35. During collective invasion after EGF stimulation, filopodia-like protrusions are 
apparent predominately in the leader cells that head the infiltrating cohort. How these protrusions of the MB cells 
are regulated in the brain tissue is not known but a better mechanistic understanding of their regulation may pro-
vide clues for targeting invasion and dissemination. Indeed, we previously implicated Ser/Thr kinase MAP4K4 in 
lamellipodia formation in MB cells invading collagen gels in response to HGF stimulation23. It now remains to be 
determined whether MAP4K4 also controls protrusion formation during tissue invasion.
We found the group 3 HD-MBO3 MB line to grow aggressively in the cerebellar slices with an expansion rate 
nearly three times higher than that of the SHH DAOY line. Although enhanced proliferation rates of this line 
probably account for most of the increased growth, it will be of outmost interest to determine whether the infil-
tration of single cells we detect or of whole cell clusters may also be a contributing factor. Therefore, future studies 
of HD-MBO3 cells stably expressing appropriate tags for microscopic visualisation combined with migration/
invasion inhibition will be necessary to clarify the contribution of cell dissemination capability to tumour expan-
sion, as was proposed recently in a seminal publication36.
Mutual interactions between the tumour cells and the host tissue have a major influence on the promotion of 
tumour development, tumour progression as well as chemo and radiosensitivity37. These interactions can now 
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be mimicked in OCSCs and they will enable the identification of factors that support MB tumour growth and 
eventually, also resistance to therapy. In this way, the co-culture system surpasses in vitro tools which are limited 
to using specific extracellular matrix components such as collagen I or matrigel, which neither mimic the mor-
phological nor the chemical complexity of the cerebellar parenchyma. Along the same lines, we have also detected 
the infiltrating tumour cells in the vicinity of or in contact with the blood vasculature. Despite the lack of vascular 
supply to the slices, we and others38 found that the capillary endothelial cells do survive in these sections and 
reorganise into tube like structures. Thus, the capillary endothelial cells most likely remain capable of expressing 
and secreting various molecules, which could influence other cells in the slice culture including the tumour cells. 
However, unlike breast and lung carcinoma cells metastasizing to the brain39, MB cells do not colonize the vascu-
lar network in the brain slices and the potential significance of their rather loose interaction with the endothelial 
network remains to be determined.
Together, we have established and validated OCSCs as a versatile platform for preclinical research of paediatric 
brain tumours. It will greatly facilitate the search for novel therapy strategies targeting growth and dissemination 
for MB and other primary brain tumours. In addition to the great spatio-temporal insight OCSCs offer in growth 
and dissemination behaviour of brain tumour cells, they also help to reduce the number of animals used in 
pre-clinical research while increasing the screening capabilities for drug testing studies.
Methods
Cells and cell lines. DAOY human MB cells were purchased from American Type Culture Collection 
(ATCC, Rockville, MD, USA) and were transduced with lentivirus pLenti-LA-EGFP23. UW22840 was generously 
provided by John Silber (Seattle, USA). DAOY and UW228 cells were cultured as described in41. The human 
glioblastoma primary cell lines ZH411 and ZH561 were generously provided by the Department of Neurology 
of the University Hospital Zürich. ZH411 and ZH561 were originally isolated from surgically removed de novo 
glioblastomas and cultured in neurobasal medium supplemented with 2% B27, 1% glutamine, epidermal growth 
factor (EGF, 10 ng/ml), and basic fibroblast growth factor (bFGF, 20 ng/ml)42. HD-MBO3 group 3 MB cells were 
obtained from Till Milde and grown as described in25.
Animals. Wild type C57BL/6JRj pregnant females were purchased from Janvier Labs and were kept in the 
animal facilities of the University of Zürich Laboratory Animal Centre. Mouse protocols for organotypic brain 
slice culture were approved by the Veterinary Office of the Canton Zürich.
Reagents. Antibodies: goat anti-GFAP (ab53554, 1:300), rabbit anti-Calbindin (ab11426, 1:1000), mouse 
anti-Calbindin (ab82812, 1:1000), donkey anti-rabbit (ab175649, 1: 100) all from Abcam and donkey anti-goat 
(A11057, 1:500), Vybrant CM-DiI cell labelling solution (V-2288) from Life Technologies, mouse anti-NeuN 
clone A60 (MAB377, 1 in 100), mouse anti-GFAP (MAB360, 1:500), rabbit anti-collagen type IV (AB756P, 
1:500), anti-nuclei clone 3E1.3(MAB4383) from Millipore, rabbit anti-cleaved caspase 3 (5A1E, 1:500) from Cell 
Signaling Technology, Click-iT EdU Alexa Fluor-647 imaging kit from Molecular Probes. HGF and EGF were 
ordered from Peprotech and used at a final concentration of 50 ng/mL and 30 ng/mL respectively. All the OCSC 
culture reagents have been described in43.
Organotypic cerebellar slice culture (OCSC). The experimental set up followed and reagents used 
were similar to the one described in43. Briefly, wild type C57BL/6JRj mice pups were sacrificed at postnatal day 
(PND) 8–10 by decapitation. Cerebella were dissected and placed in cold Geys balanced salt solution contain-
ing kynurenic acid (GBSSK). These were then embedded in 2% low melting point agarose gel in an orientation 
dependent on whether coronal or sagittal sections were needed. After the gel had solidified, the agarose block 
was glued onto the vibratome (VT 1200 S, Leica) disc with Roti Coll1 glue (0258.1 Carl Roth). The disc was then 
mounted in the vibratome chamber filled with cold GBSSK and 350 μm thick sections were cut. After removal of 
excess agarose around the slices, they were transferred to petri dishes filled with cold GBSSK. Millipore inserts 
(PICM 03050, Merck Millipore) were placed in six well plate(s) filled with 1 mL cold slice culture medium (SCM) 
onto which the slices were then transferred using a Rotilabo-embryo spoon (TL85.1, Carl Roth). A maximum 
of three slices were placed per insert and excess of medium was removed. Slices were monitored for any signs of 
apoptosis and media was changed daily for the first week and once in two days thereafter.
Formation of tumour spheroids and initiation of co-culture. For spheroid formation, 2500 cells/well 
were seeded in a 96 well Lipidure-Coat plate A-U96 (AMS-51011610, Amsbio). and incubated for 48 hours at 
37 °C, 5% CO2, 95% humidity to form spheroids. For spheroids from DAOY and UW228 cells, medium contained: 
Improved MEM (Gibco, 10373-017), 10% FBS and Pen/Strep solution, while for spheroids from HD-MBO3 cells, 
medium contained: DMEM (Sigma, D5761), 10% heat inactivated FBS, L- glutamine and Pen/Strep solution. 
Post incubation, the spheroids, of a diameter of approximately 150–200 µm, were collected from each well into 
a Falcon tube and were left for 5 minutes at room temperature (RT). Once all the spheroids had sedimented to 
the bottom of the tube, the medium was aspirated and the spheroids were re-suspended in 5 mL of SCM. 100 μl 
of suspension was collected ensuring it contained one tumour spheroid/slice and implanted by placing it on top 
of the slice at 15 days in vitro (DIV) after sectioning. Excess medium was aspirated out and the co-culture was 
maintained at 37 °C, 5% CO2, 95% humidity for at least 5 days.
Immunofluorescence protocol. The inserts were placed in a six well plate containing 1 mL of cold 4% PFA 
made in Phosphate-buffered saline (PBS) at pH 7.4. Additionally, 1 mL of cold 4% PFA was also added on top of 
the insert(s) and incubated at RT for 1 hour on a shaker. After three washes, 10 mins each with 1X PBS, the part 
of the insert, which contained the slice(s) was carefully cut under a dissecting microscope using a scalpel. The 
slices were then incubated in standard cell culture trypsin EDTA (250 μl/well of a 24 well plate) and incubated 
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at 37 °C humidified incubator for 23 minutes. The slices were then blocked in blocking solution (BS) containing 
3% foetal calf serum, 3% bovine serum albumin and 0.3% triton x 100 for 1 hour at RT. Primary antibodies were 
diluted in the same BS and incubated overnight on a shaker at 4 °C. Following 3 washes at RT using 5% BSA in 
PBS, secondary antibodies were incubated for 3 hours at RT. The inserts were flat mounted in glycergel mounting 
medium (C0563, Dako). All images were acquired on a Leica SP8 inverted confocal microscope.
For assessing proliferation, Click-iT EdU Alexa 647 Imaging kit was used (C10340, Invitrogen). Exact proto-
col as described in the kit was followed. 10 μM EdU was used and the Click-iT reaction cocktail was incubated for 
45 mins at RT. Immunofluorescence protocol was the same as above.
Vybrant Dil staining was performed as per manufacturer guidelines.
Microscopy and analysis. Images were acquired using Leica TCS SP8 inverted microscope and processed/
analysed using ImageJ. Quantification of volume and EdU-positive nuclei count was done using Imaris. Volume 
and area were quantified by rendering an isosurface. EdU positive nuclei were counted using the spots function 
and only those EdU positive spots under the GFP channel were selected.
Ethical approval. All experiments were carried out in accordance with the guidelines and regulations of the 
University of Zürich. The ex vivo experiments using cerebella of ten days old mice was approved by the veterinary 
office of the Kanton of Zürich.
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